Overview

Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment

Status:
Completed

Trial end date:
2019-07-05

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of K-877 in adult patients With Fasting High Triglyceride Levels ≥500 mg/dL and <2000 mg/dL and Mild or Moderate Renal Impairment.

Phase:

Phase 3

Details

Lead Sponsor:

Kowa Research Institute, Inc.

Treatments:

Fenofibrate